Filing Flows › Longevity Health Holdings (XAGE) › Q2 2026
Longevity Health Holdings (XAGE) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 14, 2026
Longevity Health Holdings (XAGE) reported revenue of $396K for the second quarter 2026 (Q2 2026), -21% from a year earlier and +1% from the quarter before. Operating margin was -182.9%, net loss $1.9M (475.6% of revenue).
Longevity Health Holdings, Q2 2026: revenue $396K (-21% year over year), operating margin -182.9%, net loss $1.9M, operating cash flow −$224K. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $396K | +1% | -21% |
| Operating profit | −$724K | — | — |
| Net earnings | −$1.9M | — | — |
| Operating cash flow | −$224K | — | — |
What changed
Revenue was $396K in Q2 2026, down 21% year over year and up 1% from the previous quarter.
Gross margin was 59.5%, down 0.6 points from Q2 2025. Operating costs exceeded revenue by $724K, an operating margin of -182.9%. Operating expenses fell 56% while revenue fell 21%. The quarter ended with a net loss of $1.9M, wider than the previous quarter's $1.4M loss. Net interest and other expense of $1.2M was the main reason.
Operating cash flow was −$224K. Non-cash charges added back $13K of depreciation and amortization and $79K of share-based compensation. Working capital and other items added $1.6M.
Questions
What was Longevity Health Holdings' revenue in the second quarter 2026?
Longevity Health Holdings (XAGE) reported revenue of $396K for the second quarter 2026 (Q2 2026), -21% from a year earlier and +1% from the quarter before.
Was Longevity Health Holdings profitable in the second quarter 2026?
Operating loss was $724K (-182.9% of revenue) and net loss $1.9M.